Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates
US-2026015600-A1 · Jan 15, 2026 · US
This page is not indexed by search engines while we improve data quality.
Do Hung V patents
Do Hung V is listed as an inventor on 46 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Do Hung V |
| Total patents | 46 |
| First publication | Aug 4, 2015 |
| Latest publication | Jan 15, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe Disease
US-2025381254-A1 · Dec 18, 2025 · US
Augmented acid alpha-glucosidase for the treatment of Pompe disease
US-12414985-B2 · Sep 16, 2025 · US
Disulfide Bond Stabilized Polypeptide Compositions And Methods Of Use
US-2025242057-A1 · Jul 31, 2025 · US
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
US-2025082621-A9 · Mar 13, 2025 · US
Recombinant Human Acid Alpha-Glucosidase
US-2025057925-A1 · Feb 20, 2025 · US
Compositions And Methods For Treating Mucopolysaccharidosis IIIA
US-2025034533-A1 · Jan 30, 2025 · US
Recombinant Human Acid Alpha-Glucosidase and Uses Thereof
US-2024197839-A1 · Jun 20, 2024 · US
Variant igf2 constructs
US-2024091321-A1 · Mar 21, 2024 · US
Formulations comprising recombinant acid alpha-glucosidase
US-2024066104-A1 · Feb 29, 2024 · US
Recent patents
Latest publications not already listed above.
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-11753632-B2 · Sep 12, 2023 · US
Gene therapy constructs and methods of use
US-2023233711-A1 · Jul 27, 2023 · US
Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates
US-2023203465-A1 · Jun 29, 2023 · US
Compositions useful for treatment of pompe disease
US-2023173108-A1 · Jun 8, 2023 · US
Method For Selection Of High M6P Recombinant Proteins
US-2023079225-A1 · Mar 16, 2023 · US
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-11591583-B2 · Feb 28, 2023 · US
Augmented acid alpha-glucosidase for the treatment of pompe disease
US-2022370571-A1 · Nov 24, 2022 · US
Method for selection of high M6P recombinant proteins
US-11441138-B2 · Sep 13, 2022 · US
Compositions useful for treatment of pompe disease
US-2022193261-A1 · Jun 23, 2022 · US
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-2022162578-A1 · May 26, 2022 · US
Augmented acid alpha-glucosidase for the treatment of Pompe disease
US-11278601-B2 · Mar 22, 2022 · US
Augmented acid alpha-glucosidase for the treatment of pompe disease
US-2021268074-A1 · Sep 2, 2021 · US
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-2021261935-A1 · Aug 26, 2021 · US
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
US-2021251971-A1 · Aug 19, 2021 · US
Method to predict response to pharmacological chaperone treatment of diseases
US-RE48608-E · Jun 29, 2021 · US
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-10961522-B2 · Mar 30, 2021 · US
Augmented acid alpha-glucosidase for the treatment of Pompe disease
US-10857212-B2 · Dec 8, 2020 · US
Method to predict response to pharmacological chaperone treatment of diseases
US-10813921-B2 · Oct 27, 2020 · US
Method for selection of high m6p recombinant proteins
US-2019382742-A1 · Dec 19, 2019 · US
Highly potent acid alpha-glucosidase with enhanced carbohydrates
US-2019276812-A1 · Sep 12, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amicus Therapeutics Inc | 46 |
| Univ Pennsylvania | 2 |
| Do Hung V | 1 |
| Amicus Therapeutics | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 40 |
| A61K38/47 | 36 |
| A61P3/00 | 31 |
| C12Y302/0102 | 29 |
| C12N9/2402 | 21 |